Labcorp forms strategic partnership with MD Anderson Cancer Center Foundation Spain to increase access to early phase oncology clinical trials

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 11, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced it has formed a strategic partnership with MD Anderson Cancer Center Foundation Spain, a non-profit organization whose objectives are to beat cancer and to increase accessibility of early phase oncology clinical trials.

Labcorp first national laboratory to offer monkeypox test

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 6, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced it will begin testing for monkeypox using the U.S. Centers for Disease Control and Prevention’s ( CDC ) orthopoxvirus test, which detects all non-smallpox related orthopoxviruses, including monkeypox.